The NIH's average indirect cost rate is between 27% to 28%, according to a policy statement the agency released on Friday. The statement said implementing the new rate would bring the NIH more in line ...

Today, the American Diabetes Association® (ADA) announced the awardees of the 2025 Pathway to Stop Diabetes® (Pathway) grants.  This year's grants dedicate more than $6.1 million to support ...

Omvoh has additional ongoing trials in Crohn's disease and UC, including studies to evaluate the long-term efficacy and safety of Omvoh in pediatric patients and adults, and a Phase 4 real-world ...

Convulsive therapies are an underappreciated treatment that can alleviate symptoms of severe psychiatric disorders through rapid cycles of muscle contraction ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against the ...

United Therapeutics is pioneering a new frontier in organ transplants using pig kidneys. STORY HIGHLIGHTS FDA clears United Therapeutics for human trials of pig-to-human kidney transplants.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Commercial stage pharmaceutical firm Shield Therapeutics, which has a base in Gateshead, has significantly improved its revenues and strengthened its balance sheet. The company expects to report total ...

Another biotech company, United Therapeutics, announced this week that it had received the green light from the FDA to move forward with a xenotransplant trial with its pig kidneys, which have 10 ...